| Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. CF Nathan, HW Murray, ME Wiebe, BY Rubin The Journal of experimental medicine 158 (3), 670-689, 1983 | 2523 | 1983 |
| Advances in leishmaniasis HW Murray, JD Berman, CR Davies, NG Saravia The Lancet 366 (9496), 1561-1577, 2005 | 2436 | 2005 |
| An Outbreak of Community-Acquired Pneumocystis carinii Pneumonia: Initial Manifestation of Cellular Immune Dysfunction H Masur, MA Michelis, JB Greene, I Onorato, RA Vande Stouwe, ... New England journal of medicine 305 (24), 1431-1438, 1981 | 2289 | 1981 |
| Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies JA Kovacs, JW Hiemenz, AM Macher, D STOVER, HW MURRAY, ... Annals of internal medicine 100 (5), 663-671, 1984 | 1068 | 1984 |
| The macrophage as an effector cell CF Nathan, HW Murray, ZA Cohn New England Journal of Medicine 303 (11), 622-626, 1980 | 914 | 1980 |
| Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic S Sundar, DK More, MK Singh, VP Singh, S Sharma, A Makharia, ... Clinical infectious diseases 31 (4), 1104-1107, 2000 | 819 | 2000 |
| Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome HW Murray, BY Rubin, H Masur, RB Roberts New England Journal of Medicine 310 (14), 883-889, 1984 | 675 | 1984 |
| Interferon-gamma, the activated macrophage, and host defense against microbial challenge HW MURRAY Annals of internal medicine 108 (4), 595-608, 1988 | 560 | 1988 |
| Macrophage Microbicidal Mechanisms In Vivo: Reactive Nitrogen versus Oxygen Intermediates in the Killing of Intracellular Visceral Leishmania donovani HW Murray, CF Nathan The Journal of experimental medicine 189 (4), 741-746, 1999 | 559 | 1999 |
| Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. HW Murray, BY Rubin, CD Rothermel The Journal of clinical investigation 72 (4), 1506-1510, 1983 | 532 | 1983 |
| Single-dose liposomal amphotericin B for visceral leishmaniasis in India S Sundar, J Chakravarty, D Agarwal, M Rai, HW Murray New England Journal of Medicine 362 (6), 504-512, 2010 | 488 | 2010 |
| Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. HW Murray, GL Spitalny, CF Nathan Journal of immunology (Baltimore, Md.: 1950) 134 (3), 1619-1622, 1985 | 481 | 1985 |
| Activation of human macrophages. Comparison of other cytokines with interferon-gamma. CF Nathan, TJ Prendergast, ME Wiebe, ER Stanley, E Platzer, ... The Journal of experimental medicine 160 (2), 600-605, 1984 | 470 | 1984 |
| The protean manifestations of Mycoplasma pneumoniae infection in adults HW Murray, H Masur, LB Senterfit, RB Roberts The American journal of medicine 58 (2), 229-242, 1975 | 390 | 1975 |
| Rapid accurate field diagnosis of Indian visceral leishmaniasis S Sundar, SG Reed, VP Singh, PCK Kumar, HW Murray The Lancet 351 (9102), 563-565, 1998 | 359 | 1998 |
| Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages HW Murray The Journal of experimental medicine 153 (5), 1302-1315, 1981 | 331 | 1981 |
| Clinical and experimental advances in treatment of visceral leishmaniasis HW Murray Antimicrobial agents and chemotherapy 45 (8), 2185-2197, 2001 | 322 | 2001 |
| Trial of oral miltefosine for visceral leishmaniasis S Sundar, F Rosenkaimer, MK Makharia, AK Goyal, AK Mandal, A Voss, ... The Lancet 352 (9143), 1821-1823, 1998 | 311 | 1998 |
| Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy HW Murray, CM Lu, S Mauze, S Freeman, AL Moreira, G Kaplan, ... Infection and immunity 70 (11), 6284-6293, 2002 | 307 | 2002 |
| Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. HW Murray, CW Juangbhanich, CF Nathan, ZA Cohn The Journal of experimental medicine 150 (4), 950-964, 1979 | 305 | 1979 |
